Caribou Biosciences, Inc. (CRBU) vs MediciNova, Inc. (MNOV)
Caribou Biosciences, Inc. and MediciNova, Inc. are both Biotechnology companies. Caribou Biosciences, Inc. and MediciNova, Inc. are of similar size ($134.0M and $132.9M). Caribou Biosciences, Inc. grew revenue faster over the last twelve months: 10.0% against −82.2%. Caribou Biosciences, Inc. has the higher net margin (−1,030.4% vs −1,168.3%) and the higher return on invested capital (0.00% vs −62.5%). Across the 16 metrics below, Caribou Biosciences, Inc. leads on 10 and MediciNova, Inc. on 6.
Valuation
Profitability
| Metric | CRBU | MNOV | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 37.76% | 65.16% |
| Operating margin | (1,090.90%) | (1,287.53%) | 0.00% |
| Net margin | (1,030.42%) | (1,168.31%) | 0.00% |
| Free cash flow margin | (1,323.30%) | (991.31%) | 0.00% |
| Return on equity | (78.27%) | (25.56%) | (57.72%) |
| Return on assets | (56.87%) | (23.83%) | (49.22%) |
| Return on invested capital | 0.00% | (62.48%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack